Search Results 461-470 of 15849 for Conduction

1. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   Evidence of any of the following cardiac conduction abnormalities during the screening period: A QTc Fredericia interval >450 milliseconds for males and ...

2. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...

3. Cardiovascular Diseases and Cardiac Surgery Resource Center - Medical Professionals - Mayo Clinic

   5. New anatomy for the cardiac conduction system discovered by Mayo Clinic cardiology researchers · Medical Professionals; Cardiovascular Diseases and Cardiac ...

4. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

   Subjects with evidence of intraventricular conduction delay, defined as a QRS interval greater than 110 msec, will be excluded if the QTcF is >500 msec for ...

5. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

6. Neck pain - Doctors and departments - Mayo Clinic

   ... conduction study, Injection, Osteoarthritis, Back pain, Cervical myelopathy, Neck pain, Brachial plexus injury, Herniated disk, Arthritis, Bursitis ...

7. A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures - Mayo Clinic

   Patients with myocardial compromise or cardiac conduction defects because of magnesium's anti-inotropic effects. Patients with renal insufficiency ...

8. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... conduction system abnormalities unless subject has a pacemaker; Subject has plasma cell leukemia or Waldenstrom's macroglobuleinemia or POEMS syndrome ...

9. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Severe uncontrolled ventricular arrhythmias or electrocardiographic evidence of active conduction system abnormalities; Cardiac amyloidosis with hypotension ...

10. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    ... conduction system abnormalities. Prior to the first dose of study treatment, any electrocardiogram (ECG) abnormality at screening must be documented by the ...